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THE EFFECTS OF MECHANICAL STRAIN ON ADHESION IN MYH9-
ABLATED PODOCYTES 
KEITH HOLLIS KELLER 
ABSTRACT 
Myh9 is a gene that encodes for non-muscle myosin IIA (NM-IIA), an actin 
cytoskeleton component and protein involved in cell movement and adhesion in most 
cells, including podocytes. Autosomal dominant mutations in NM-IIA have been 
associated with focal segmental glomerular sclerosis (FSGS) in patients with the 
mutation. Furthermore, a strong association has been discovered between genetic 
variation in the Myh9 region on chromosome 22, and the increased risk of chronic kidney 
disease in African Americans. Later studies by Johnstone et al. using podocyte specific, 
Myh9 KO in mice showed that knocking out this gene alone was not enough to cause 
proteinuria or glomerular sclerosis. However, in our own laboratory we have found that 
when these same mice are exposed to models of glomerular hypertension, glomerular 
damage is promoted. This damage was preceded by evidence of podocyte loss in urine 
and tissue. Podocyte loss is a hallmark of kidney disease, and while it is known to occur 
in vivo, the mechanisms behind this phenomenon are unknown. It is believed that 
increase in glomerular capillary blood pressure is likely to be a strong contributing factor. 
Based on these findings, we hypothesized that the mechanical strain in the form of 
stretch, occurring during hypertension, may act as a second hit to Myh9 ablation in 
podocytes, causing changes in podocytes ability to adhere to the glomerular basement 
membrane (GBM), ultimately leading to the pathology seen in patients. To test this, we 
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knocked down Myh9 in immortalized mouse podocytes cultured on flexible silicon 
membranes and exposed them to mechanical stretch for 24hrs. Cell adhesion was 
evaluated via cell attachment assays. Cell morphology and focal adhesions (FA) were 
examined using immunofluorescence and quantified using imageJ. Our results showed a 
significant decrease in transduced cells attached to the membrane after stretch, as well as 
an increase in FA size and number in cells that underwent stretch, except in Myh9 
knockdown cells. Cells with Myh9 knockdown also showed marked increase in area, 
with a decrease in FA size and number after exposure to stretch. These results support our 
hypothesis that Myh9 mutations may be a contributing factor to podocyte loss in patients 
with hypertension and chronic kidney disease.  
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INTRODUCTION 
 The primary role of the kidney is to filter blood. Filtration occurs when blood passes 
through the glomerular capillary filtration barrier, composed of the fenestrated 
endothelium, followed by the porous GBM, and finally the slit diaphragm of the podocyte 
foot processes, collectively creating a highly specific filtration sieve based on molecular 
size and charge 1–3. Filtered water and solutes, termed ultrafiltrate, having passed through 
the glomerular filtration system, accumulate in the Bowman’s space and eventually drain 
into the renal tubular system.  In the tubular system, the composition of the ultrafiltrate is 
modified, leaving waste products that are expelled in the urine.  
The podocyte is a specialized, kidney-specific epithelial cell that adheres to the 
outside of the glomerular capillary, via the glomerular basement membrane (GBM). It is 
comprised of a podocyte cell body, major processes, and many interdigitating, finger-like 
structures called foot-processes (Fig 1). Interdigitated foot processes are linked via the 
formation of the slit diaphragm, which is a specialized cell-cell junctional complex 
composed of nephrin, a-cadherin and other podocyte-specific proteins (Fig 2). This highly 
functional cell serves many purposes in the kidney, ultimately to facilitate the filtration of 
blood.  For instance, it likely serves as the primary impediment to the flow of water across 
the glomerular filtration barrier, and it contributes to the structure of the GBM through 
synthesis of GBM proteins4.  However, in addition to these more direct contributions to the 
glomerular filtration barrier, the podocyte is also believed to provide structural support for 
the glomerular capillaries.  In this role, the podocyte may counteract the distending forces 
generated by normally high capillary blood pressure required for ultrafiltration, as well as 
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other acute high-blood pressure events such as stress or moments of increased cardiac 
activity 5,6.  
Podocyte adhesion to the GBM is regulated via a complex interaction between the 
cytoskeleton of the podocyte foot processes and the matrix proteins of the GBM (Fig. 2). 
The podocyte foot process actin cytoskeleton is comprised of numerous structural proteins, 
including actin, myosin-II and synaptopodin. Adhesion to the GBM matrix is mediated 
through the linkage of the actin cytoskeleton to adhesion complexes via linker proteins 
such as talin, filamin and a-actinin 5–9. It is known that the integrity of the foot process slit 
diaphragm and the FP:GBM complex is affected in a number of kidney diseases. Loss in 
slit diaphragm integrity leads to a common pathology know as effacement, characterized 
by loss of slit diaphragms and the widening of foot process.  Loss of FP:GBM integrity can 
result in the detachment of entire podocytes from the GBM. While effacement is a common 
pathology in kidney disease, and podocyte loss is emerging as an important process in 
chronic kidney disease, the mechanisms behind these phenomena remain unknown. 
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Figure 1: Glomerular filtration apparatus. The diagram at lower left shows a capillary 
loop segment from a glomerulus. Mesangial cells support the mesangium, which anchors 
the glomerular capillary loop to the glomerular tuft. Particles in the blood passing through 
the capillary lumen (CL) are filtered through the fenestrated endothelium (EC), through the 
GBM and finally past the slit diaphragm (arrowheads) of the foot processes (FP) into the 
Bowman’s space (BS). Cartoon by Dr. Mostafa Belghasem. Ultrastructual image of mouse 
kidney at upper right taken at 50,000X by James Stevenson. Figure taken from 10.   
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Figure 2: Structural components of the podocyte foot processes. Diagram of foot 
processes in cross section shows protein components of foot process (tan) and slit 
diaphragm (white with green outline).  Cas: p130Cas; Cat: catenins; CD: CD2-associated 
protein; Ez: ezrin; FAK: focal adhesion kinase; ILK: integrin-linked kinase; M: myosin; 
N: NHERF2; NSCC: nonselective cation channel; PC: podocalyxin; S: synaptopodin; 
TPV: talin, paxillin, vinculin; U: utrophin; Z: ZO-1 (Taken from Pavenstädt H, Kriz W, 
Kretzler M. 2003) 5 
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Chronic Kidney Disease: A Global Burden  
Chronic kidney disease (CKD) affects 10% of the global population, 25% of all 
people over the age of 65, and was ranked 18th in the list of causes of total number of deaths 
worldwide in 2010 11. Such a large global disease prevalence presents financial burden not 
only on suffering individuals, but also on the healthcare budget of the government of those 
affected. In the United States, at over $70,000 per individual affected, CKD costs Medicare 
over $42.5 billion dollars annually. 12. Patients progress from CKD to end stage renal 
disease (ESRD) when the kidney can no longer support the bodies’ physiological demands.  
ESRD patients ultimately are left with two treatment options: dialysis and/or transplant.  
Approximately 10% of patients with ESRD die within 5 years of diagnosis regardless of 
treatment option. Treatment of ESRD costs Medicare over $48 billion annually, accounting 
for 6.7% of the annual Medicare budget. While ESRD rates have plateaued over the last 
15 years in the United States, CKD remains a globally important disease that deserves 
increased research efforts.  
 
Glomerular Hypertension: A Central Cause of Chronic Glomerular Damage 
28.4% of ESRD cases are caused by hypertension, with an increase in incidence 
of 7.7% between 2000 and 2010. 13 Glomerular hypertension occurs when pre-glomerular 
vasculature regulation of blood pressure (renal autoregulation), responsible for 
maintaining constant flow through the glomerular apparatus even with drastic changes in 
blood pressure, becomes defective, resulting in increased distending force on the 
glomerular capillary wall (Endlich et al., 2005). This increase in pressure causes 
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circumferential tensile wall stress, or “stretch”, that is felt, and acted against, by elastic 
and contractile properties of the podocyte FPs cytoskeleton 4,14. It is believed that this 
increase in glomerular capillary blood pressure is likely to be a strong contributing factor 
to podocyte loss (Fig. 3) 15–17. Glomerular capillary hypertension and associated 
structural deformations develop as a consequence of a large array of chronic kidney 
diseases and have been shown to cause podocyte damage and further the progression of 
glomerular sclerosis and proteinuria 18–20. 
 
 
Figure 3: Glomerular hypertension leads to podocyte loss. A) Under normal conditions 
capillaries experience pressures of ~55 mmHg, causing wall tension that is resisted by the 
GBM and the podocyte foot processes 21. B) During high blood pressure events, wall 
tension is increased, causing changes in the physiology and structure of the podocyte slit 
diaphragm (SD) and foot processes (FP) as well as the glomerular basement membrane 
(GBM). C) Prolonged glomerular hypertension is believed cause podocyte effacement and 
eventually podocyte loss. Figure created by, and reproduced with the permission of Dr. 
Mostafa Belghasem.   
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Non-Muscle Myosin IIA and the Podocyte 
Myh9 is a gene that encodes for non-muscle myosin IIA (NM-IIA), an actin 
cytoskeleton component and protein involved in cell movement and adhesion in most 
cells, including podocytes. Autosomal dominant mutations in NM-IIA have been 
associated with focal segmental glomerular sclerosis (FSGS) in patients with the 
mutation 22. Furthermore, a strong association has been discovered between genetic 
variation in the Myh9 region on chromosome 22, and the increased risk of chronic kidney 
disease in African Americans 23. Later studies by Johnstone et al. using podocyte specific, 
Myh9 KO in mice showed that knocking out this gene alone was not enough to cause 
proteinuria or glomerular sclerosis 24. However, Belghasem et al. have found that when 
these same mice are exposed to models of glomerular hypertension, glomerular damage 
is promoted (Belghasem, Bondzie et al., in preparation).  This damage was preceded by 
evidence of podocyte loss in urine and tissue (Belghasem, Bondzie et al., in preparation).  
Thus NM-IIA appears to be most important in podocyte structure and function 
specifically when glomerular capillary hypertension occurs. 
 
Response of Podocytes to Mechanical Strain: What is the Role of Non-Muscle 
Myosin IIA? 
 Many cell types experience mechanical strain due to a number of mechanisms, 
ranging from muscles and connective tissues experiencing compressing and elongating 
strain to vascular cells undergoing stretch due to changes in blood pressure. While not all 
these forces are pathological, it is clear that mechanical stretch is a hallmark of vascular 
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hypertension 25–27. To study the effects of mechanical stress on endothelial cells, cells are 
often plated on flexible silicone membranes and stretched in a biaxial fashion. These 
membranes can be cyclically stretched and relaxed using a vacuum that simulates the 
cardiac cycle. Experiments such as these have been used to study a number of cell types 
in the kidney, since kidney vasculature experiences a wide range of blood pressure 
changes 6,14,28.  Given the apparently important role of mechanical strain on podocyte and 
glomerular pathology, a number of stretch studies have been performed on these cells 
since 2001 (Table 1). Among the findings of these studies was that cyclic, biaxial strain 
resulted in changes in the actin/integrin system. Furthermore, podocyte-specific ablation 
of NM-IIA has been shown to lead to fewer focal adhesion points, and decreased cell 
attachment in podocytes in vitro 29. These in vitro results suggest that mechanical strain 
due to hypertension may alter podocyte adhesion in vivo 3,7. It is from these experiments, 
and those on NM-IIA’s role in podocyte adhesion, that we derived our hypothesis for this 
project: glomerular hypertension may act as a second hit leading to the glomerular lesions 
seen in patients suffering from mutations in, or genetic alterations in the vicinity of 
Myh9.  Using the experimental design presented in Figure 4, we aim to quantify 
morphologic and molecular changes associated with adhesion in Myh9-ablated and 
control podocytes at the light-microscopy level and protein level, under conditions of cell 
strain (Fig 4).  To do this, we quantified cytoskeletal and adhesion related protein 
production, and performed a morphometric analysis of Myh9 ablated, mechanically 
strained podocytes.  The results of these studies are reported in the following chapters. 
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Table 1. Previous podocyte stretch experiments. Summary of cyclic stretch 
experiments performed on podocytes from 2001-2012, using either the Flexcell apparatus 
or S-1 CLS stretch apparatus. Strain magnitudes vary from 1-20%. Table taken from 
Endlich and Endlich, 2007 7. 
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Figure 4. Experimental design. 
Culture	cells
Adhesion/Cell	
death	assay
Fix	Cells	in	
stretched	
conformation
IF	staining
Morphologic	
analysis
Extract	protein	
from	whole	cell	
lysate
Western	blot	
analysis
Transfect	cells
Replate to	
Flexcell
Stretch	cells
Transduce
	11 
METHODS  
 
Cell Culture 
For pilot studies, primary human podocytes were cultured on 10 cm gas treated 
polystyrene tissue culture plates in 5% CO2 environment with complete RPMI 1640 with 
L-glutamine medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) 
and 1% antibiotic-antimycotic (CORNING Inc., Corning, NY). Media was removed, 
cells were rinsed with 1X PBS and fresh media added every second day. Immortalized 
murine epithelial cells (podocytes) were cultured as described by Shankland et al.30 These 
cells expressed temperature sensitive SV40 large T-antigen, and were propagated under 
“permissive” (proliferative) conditions in the presence of g-IFN at 33°C, until ~85% 
confluence. Cells were then passaged and moved to “non-permissive” (non-proliferative, 
differentiation-inducing) conditions, including thermoshift to 37°C, and switch to g-IFN 
free media to induce cell cycle arrest and terminal differentiation over the next 14 days. 
Pilot studies revealed the optimal seeding density to be 2x105 cells/10cm culture dish 
upon passaging and moving to 37°C.   
 
Lentiviral RNA Interference System 
Lentiviral vectors containing short-interfering RNA (siRNA) designed to interfere 
with Myh9 (KD) as well as non-targeting control vectors (V.CTL) were used from 
previous work in our lab described in Bondzie et al. 29 .  Lentiviral supernatants were 
prepared as previously described31. Briefly, 293T cells cultured in DMEM, supplemented 
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with 10% FBS and 1% antibiotic-antimycotic, were transfected with specific siRNA-
encoding VIRHD/E plasmids, along with plasmids pCMVdelR8.91 and pVSV-Env, 
encoding for lentiviral packaging proteins (Table 2). Transfection was accomplished 
using Fugene6 reagent at a ratio of 3:1, plasmid mixture (2:2:1 (VIRHD/8.91/VSV-Env)) 
to DNA.  24hrs after transfection, media was replaced with fresh cDMEM, and 48hrs 
later, media containing lentiviral particles synthesized by the transfected 293T cells was 
filtered, aliquoted and stored at -80°C. Murine podocytes were transduced 24hrs after 
theremoshifting to 37°C, with lentivirus supernatant. Transduction was confirmed 48hrs 
post-transduction by GFP epifluorescence.  
  
Table 2.  Sequences of hairpin siRNA oligomers cloned into VIRHD/E plasmids later 
transfected into 293T cells for production of lentivirus used for podocyte transduction 
and Myh9 knockdown.  Sense (“S”) and anti-sense (“AS”) sequences of both Myh9 
knockdown (“Myh9 2740”) and GC content-matched control (“Ctrl 2740”) lentivirus 
preparations are shown. 
Myh9 2740 S 
P 5’-GATCCG-(GACAAAGGTTCGAGAGAAA)-(TTCAAGAGA)-(TTTCTCTCGAACCTTTGTC)- TTTTTTGGAAG-3’  
 
Myh9 2740 AS 
P 5’-AATTCTTCCAAAAAA-(GACAAAGGTTCGAGAGAAA)-(TCTCTTGAA)- (TTTCTCTCGAACCTTTGTC)-CG-3’  
 
Ctrl 2740 S 
P  5’-GATCCG-(GGAGAACGAGTAATCAGAA)-(TTCAAGAGA)-(TTCTGATTACTCGTTCTCC)- TTTTTTGGAAG-3’  
 
Ctrl 2740 AS 
P  5’-AATTCTTCCAAAAAA-(GGAGAACGAGTAATCAGAA)-(TCTCTTGAA)- (TTCTGATTACTCGTTCTCC)-CG-3’  
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Cell Stretch Experiments 
Primary human podocytes.   
Upon confluency, primary human podocytes were suspended in Trypsin-EDTA 
and re-plated onto flexible, collagen type-IV treated silicone membranes (Flexcell Int, 
Burlington, NC). After 24hrs to allow attachment, media was replaced with serum-free 
RPMI media for 24hrs. Cells were then given fresh serum-free media and statically 
stretched at maximum tension obtainable by the Flexcell (~20% over unstretched). 
Stretch was performed using a manually-operated fixture developed within our laboratory 
(Fig. 5) which allowed for stretching of three experimental well and 3 unstretched, 
control wells. Briefly, cells in experimental wells were stretched over loading posts, in 
between two Plexiglas plates. Stretch magnitude was measured, using Image-J, by 
calculating the percent change in distance between two points on the unstretched 
membrane before and after stretch. Cells were stretched for 1hr, 6hrs, 12hrs, 24hrs and 
48hrs, via independent experiments. After stretching, cells were lysed and protein 
extracted (data not shown).  
Immortalized murine podocytes.   
Experiments involving Myh9 siRNA-ablated and control murine podocytes were 
performed as follows (see Fig 6): 11 days after lentiviral transduction, immortalized 
murine podocytes (lentivirus-transduced and untreated) were plated on Flexcell 
membranes as previously described. The 6-well plate was divided into three experimental 
groups; control (untreated) cells, lentiviral control cells expressing a non-targeting siRNA 
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sequence, and lentiviral Myh9 siRNA knock-down cells.  For each experiment, each 
experimental group was represented in one stretched and one unstretched well, for a total 
of six wells utilized.  Cells remained in cRPMI (RPMI, 10% FBS, 1% antibiotic-
antimycotic) for 24hrs, whereupon media was transitioned to serum-free media over three 
days (Fig. 6). 
 
 
 
Figure 5: Cell stretching device. Cells are seeded on Flexcell flexible 0.5mm thick silicon 
membranes in a standard 6 well configuration, coated with collagen type-IV (Flexcell Int, 
Burlington, NC). Each well of the 6 well plate is 10cm2 in total surface area. The device is 
comprised of a “sandwich” whereby the 6 well plate is placed between upper and lower 
Plexiglas plates, with poly vinyl chloride (PVC) discs affixed to the lower plate, directly 
under experimental (stretched) wells.  For experiments described here, 3 wells received 
PVC discs and were stretched, as shown. Membrane stretch is achieved by placing the 
entire assembly (Plexiglas plates, 6 well plate, PVC disks) between two, 2” C-clamps, and 
tightening the clamps to push down on the 6 well plate relative to the PVC disks, which 
simultaneously push upward on the membrane, thereby stretching the membrane over the 
top of the PVC posts (see figure). Maximum stretch allowed by the Flexcell is 20%. All 
tools were sterilized using 70% ethanol prior to use. Image courtesy of Dr. Mostafa 
Belghasem.   
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After three days, cells were given fresh serum-free media and stretched for 24 hrs. After 
each time point cells were fixed in 4% PFA for 5 minutes at room temperature, in their 
stretched state. Cells were then stained for adhesion and cytoskeletal proteins, and 
membranes were removed from the six well plate, mounted on slides, and analyzed using 
immunofluorescence microscopy.  
 
 
Figure 6: Cell culture timeline. Cells were incubated for 7 days at 33C in cRMPI 1640 
containing 10% FBS, 1% APC, in the presence of g-IFN to induce proliferation. Upon 
reaching ~85% confluence (typically day 7), cells were thermoshifted to 37C and cRPMI 
1640 without g-IFN, to halt proliferation and induce terminal differentiation. 24 hours 
after shifting to 37C, cells were transduced by exposing cells to the lentiviral interference 
system for 24 hours (days 8 to 9). Virus was then removed and fresh media replaced. 
After 10 days at 37C cells were replated on Flexcell 6-well plate (day 18). Over the next 
three days, media was steadily changed from standard to serum-free media through 
graded serum concentrations of 10%, 7%, 3%, ands serum-free for 24 hrs each. On day 
22, after 24 hrs in serum-free media, cell stretch experiments were performed.  
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Western Blot Analysis 
For Western blot analysis, cells were lysed in lysis buffer containing protease 
inhibitor and phosphatase inhibitors at 1:100 dilutions in radioimmunoprecipitation assay 
(RIPA) buffer. Cells were then scraped from the membrane and whole lysate plus buffer 
was transferred to the next experimental well. Steps were repeated for control wells. 
Lysates were rocked on ice for 20 minutes then centrifuged at 4°C at 14000rpm for 10 
minutes. Supernatant was aliquoted and stored at -80°C. Protein concentration was 
measured using Pierce BCA protein assay kit according to the manufacturer’s directions 
(ThermoScientific, Waltham, MA). Briefly, 25ul of protein was added to 25ul BCA 
solution and incubated at 37°C for 30 minutes. Protein concentration was then measured 
using a Nano-drop machine (ThermoScientific, Waltham, MA). Protein concentration 
was standardized to the time point with the lowest concentration, boiled in SDS for 5 
minutes, subjected to SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) 
membrane. The PVDF membrane was blotted for primary antibodies against human NM-
IIA (Abcam, Cambridge, United Kingdom) and vinculin (Life Technologies, Carlsbad, 
CA) and secondary horseradish peroxidase-conjugated anti-mouse or anti-rabbit. 
 
Immunocytochemistry 
Cells fixed in 4% paraformaldehyde (PFA) were permeabilized using 0.3% Triton 
X in PBS for 5 minutes. Following permeabilization, cells were washed with PBS, and 
blocking buffer (Triton X, Donkey Serum, BSA) was applied for 45 minutes at room 
temperature. After blocking, the flexible silicon membrane was removed from the 
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Flexcell plate and divided into small squares, allowing for multiple staining experiments 
of the same membrane, and placed onto glass slides in a humidified chamber. Podocytes 
were then incubated for 1hr at room temperature with primary antibodies again mouse 
NM-IIA (Abcam, Cambridge, United Kingdom) and vinculin (Life Technologies, 
Carlsbad, CA) at dilutions of 1:100 and 1:20 respectively. Cells were then washed with 
PBS then incubated for 30 minutes with Cy-2 conjugated secondary antibodies (Jackson 
Immunology, West Grove, PA) at 1:100 dilution. Cells were also stained for 30 minutes 
with blue or rhodamine phalloidin (Thermofisher, Waltham, MA) to visualize 
filamentous actin and 4’,6-diamidino-2-phenylindole (DAPI) (Invitrogen, Carlsbad, CA) 
to visualize nuclei. Fluorescence mounting medium (Dako, Carpinteria, CA) and 
coverslips were applied, and sealed with clear nail polish. Pictures were taken of 
representative cells at identical exposure settings.   
 
Cell Attachment Assay 
 Flexcell plates were seeded and stretched as previously described with 6000 cells 
per well from each experimental group. After stretching, cells were washed twice with 
1X PBS to remove dead cells. Cells were then fixed in 4% paraformaldehyde for 5 
minutes at room temperature. Each cell population was then counted at 4X magnification 
by selecting 10 separate fields of view (FOV) in a grid like fashion. Total cell number 
was calculated by multiplying the area of the well by the averaged cell count and dividing 
by the FOV area.     
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Focal Adhesion Assay 
 A minimum of 25 cells per experimental group were imaged, using Olympus 
BX60 fluorescent microscope and camera, at 40X. Transduced cells were determined by 
GFP epifluorescence. Cells stained for vinculin were analyzed for focal adhesion (FA) 
number and size using the particle analysis feature of imageJ. Cell area was measured 
using imageJ. Transfected cells were selected for analysis based on their expression of 
GFP, while those without were excluded. Focal adhesion distribution was evaluated 
manually by assigning each cell counted a binary score for each condition of peripheral, 
diffuse or not present; 1= condition present, 0= condition not present. “Peripheral” cells 
were defined as having the majority of their FAs on the edge of the cell, whereas 
“diffuse” cells contained FAs throughout the cell.   
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RESULTS 
 
 
Lentiviral Transduction is Effective in Cultured Murine Podocytes 
 First, we sought to confirm that it is possible to use lentiviral siRNA to knock 
down Myh9/NM-IIA in murine podocytes, while cultured in our stretch application 
system.  Using fluorescent microscopy, images were taken of murine podocytes 
immediately after being replated on the Flexcell plate, approximately 10 days after 
lentivirus exposure, to confirm lentiviral transduction (Fig. 7). Cells transduced with 
lentivirus fluoresce green in their nuclei (V.CTL and KD), while untransduced cells show 
no epifluorescence (WT). As indicated by Fig. 7, high efficiency transduction was 
accomplished for both Myh9 knockdown and control lentivirus treatments, with nearly all 
cells showing some degree of fluorescence.  Untreated (wild type) cells show no 
fluorescence.  Further confirmation of Myh9 knockdown was obtained using Western 
blot (Fig. 8).  
 
Western Blot  
 Western blot was performed to confirm NM-IIA knockdown in cells exposed to 
appropriate lentivirus, and to determine if either NM-IIA knockdown or exposure to 
stretch resulted in any changes in vinculin protein concentration in the cells.  Vinculin is 
a protein associated with focal adhesions, therefore changes in its cellular concentration 
could indicate changes in focal adhesion structure or presence.   
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Western blot of protein lysates from each of the experimental groups suggested 
that NM-IIA was markedly reduced in the transduced groups relative to the WT control, 
as evidenced by the decreased density of the bands (Fig. 8).  In particular, NM-IIA is 
least evident in the KD-ST group, which strongly suggests that the lentiviral knockdown 
was effective.  In contrast, vinculin is evident in each of the control groups, although 
concentration appears to be somewhat reduced in the lentivirus-exposed groups relative 
to the WT controls.  There was no clear effect of stretch on vinculin band density.  
However it is difficult to make definitive conclusions about changes in relative protein 
concentration in these studies, as lysate concentration measurements were unable 
determine protein concentration for each experimental group, likely due to low protein 
concentrations for each group (see discussion).   
 
Lentiviral Transduction Leads to a Marked Decrease in Cellular Attachment 
 A cellular attachment assay was performed to examine the effect of Myh9/NM-
IIA gene knockdown, and mechanical strain, on differentiated podocytes ability to adhere 
to the Flexcell membrane (Fig. 9).  After initial plating, control cells continued to 
proliferate on the Flexcell plate resulting in an overall increase in cellular number, by 
77% and 120% in CTL and CTL-ST groups respectively. V.CTL and V.CTL-ST show a 
decrease in cellular number by 53% each.  KD and KD-ST showed the greatest decrease 
in cellular attachment with 50% and 60% decreases, respectively. While these results 
suggest a residual proliferative capability in “wild type” (untreated) cells, and a strong 
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effect of lentivirus exposure on cellular attachment, there is no clear indication that 
stretch exposure or NM-IIA knockdown has a role in podocyte attachment in this system. 
 
Stretch is associated with an increase in total focal adhesion area in murine 
podocytes; ablation of Myh9 alters normal response of focal adhesions to stretch 
 Focal adhesion analysis (Fig. 10) showed that mean focal adhesion area increased 
with stretch in each experimental treatment group except KD (CTL: 1.41+ 1.62 µm2; 
CTL-ST: 2.12+ 3.13µm2; V.CTL: 0.54+ 0.47µm2; V.CTL-ST: 2.77+ 3.59µm2; KD: 
3.04+ 2.57µm2; KD-ST: 2.09+ 1.13µm2) (Fig. 11A). All three groups show an increase in 
the total area of FAs per cell when exposed to stretch (Fig 11B). The total number of FAs 
per cell remained about the same between all experimental groups, except for the KD-ST 
group which showed a substantial decrease in FA number (Fig. 11C).  
Within the CTL groups, stretched cells shifted FA distribution from diffuse to 
peripheral, whereas V.CTL cells changed from peripheral distribution to a more diffuse 
pattern in stretched cells. Interestingly, there was no apparent stretch-associated change 
in FA distribution in the KD groups (Table 2).   
 
Myh9 ablation is associated with increased cell size 
Mean cell size was drastically larger in the KD groups (CTL: 773.6+489.µm2; 
CTL-ST: 505.5+377.7µm2; V.CTL: 817.6+1008,5µm2; V.CTL-ST: 1306.9+787µm2; 
KD: 3576.5+2694.7µm2; KD-ST: 5461.7+13,456.3µm2). This is consistent with earlier 
findings in Myh9-ablated cells (Bondzie et al).  One cell in the KD-ST group was more 
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than three-times as large as the next largest cell in its own group and the largest in any 
other group (Fig. 12).  
   
 
Figure 7: GFP epifluorescence confirmation of lentiviral transduction. Brightfield 
phase contrast (left column) and GFP epifluorescence (right column) images taken 10 
days after lentivirus treatment.  Top to bottom: Wild type (WT) cells show no 
epifluorescence, as expected, while vector control (V.CTL) and Myh9 knockdown (KD) 
cells do, confirming lentiviral transfection in most cells. All images taken at 20X 
magnification. 
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Figure 8: Western Blot of NM-IIA and Vinculin, showing presence and quantity of 
these proteins in cells in each of six experimental groups. Equal volumes of cell lysate 
were loaded in each lane. Presence of vinculin was confirmed in all experimental groups 
although quantity appears diminished in lentivirus-treated groups. NM-IIA appears to be 
decreased in transduceed groups, in particular KD-ST, relative to vinculin.  
KD=knockdown, V.CTL= lentiviral control, CTL=untreated (wild type), ST=stretched 
(cells corresponding to lanes unlabeled with “ST” were not stretched). 
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Figure 9: Cellular Attachment Assay.  Comparison of plated cells (solid black bars) to 
cells post stretch (ST) (shaded bars). CTL cells show increase in cellular number, while 
those transfected with the lentivirus show marked decrease. Stretched KD cells show the 
largest decrease in cellular number.   
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Figure 10: Vinculin Stain: Murine podocytes stained with vinculin were imaged at 40X 
and analyzed using imageJ. Bright spots indicate vinculin FAs.  
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Figure 11: Description of Focal Adhesions. A) Average FA size. FA size varied little 
on average except for V.CTL, which was smaller. B) Cellular FA area expressed as a 
percentage of the cell taken up by each FA. Stretch increased the area of cell taken up by 
focal adhesions in all experimental groups. C) Total number of FAs per cell. The total 
number of FAs in each cell was very similar between experimental groups. Analysis was 
performed using imageJ on images taken at 40X magnification.   
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Figure 12: Cellular area. The cellular area was close between all groups except for the 
KDs where cells were markedly larger.  Analysis was performed using imageJ on images 
taken at 40X magnification.   
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Table 3: Focal Adhesion Distribution. Comparison of FAs for all experimental groups. 
CTL-ST showed a shift from peripheral to diffuse distribution in FAs. V.CTL-ST showed 
an increase in diffuse FA distribution when compared to its non-stretched counterpart. 
There was no apparent change in FA distribution in the KD groups. 
 
 
 
 
 
 
 
 
 
 
 
Experimental	
Group
Number	of	Cells	
Observed
Peripheral	FA No FA Diffuse	FA
CTL 30 23%	(n=7) 0 77%	(n=23)	
CTL-ST 31 7% (n=2) 48%	(n=15) 45%	(n=14)
V.CTL 26 15%	(n=4) 4%	(n=1) 8%	(n=21)
V.CTL-ST 29 62%	(n=18) 14%	(n=4) 24%	(n=7)
KD 21 24%	(n=5) 19%	(n=4) 57%	(n=12)
KD-ST 22 36%	(n=8) 9%	(n=2) 55%	(n=12)
Focal	Adhesion	Distribution
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DISCUSSION 
 
 Previous studies by Johnstone et al. have shown that podocyte specific knock 
down of Myh9 does not in itself cause the disease phenotype as seen in patients with 
genetic ablations of Myh9 23.  This study aimed to recapitulate, in vivo, the disease 
phenotype seen in those with genetic loss of Myh9, by using an RNAi system to 
knockdown Myh9 in cultured mouse podocytes, and employing a second hit of 
mechanical strain. To evaluate our model’s efficacy, we used a variety of microscopy 
techniques to examine cellular attachment, focal adhesion (FA) alteration and western 
blot to quantify changes in adhesion protein in these mechanically strained cells. Our 
morphometric observations suggest that Myh9 ablation is associated with altered FA 
morphology under quiescent conditions.  Further, exposure to stretch normally increases 
the size, number and proportion of cell occupied by FAs, and Myh9 ablation alters this 
response.  
 We hypothesized that mechanical strain, in the form of a step change in stretch, 
may represent a second hit which precipitates podocyte loss and subsequent glomerular 
damage, in vivo.  We utilized a commercially available system that allows for application 
of stretch to cultured cells, in order to test this hypothesis in vitro.  Using this system, we 
measured changes in cell attachment resulting from application of a step increase in 
strain.  In control cells not exposed to lentivirus, we observed a slight increase, over the 
normal increase in cell attachment and/or proliferation after plating, in response to stretch 
(Fig 9).  This suggests that normally, cells may increase their ability to adhere when 
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exposed to mechanical stimuli.  Similar effects have been observed in more widely 
studied in vitro models, such as cultured endothelium 32.  Cells that were exposed to 
control and Myh9 KD lentivirus, however, all showed a marked decrease in cell 
attachment whether exposed to stretch or not (Fig 9).  This indicates that the lentiviral 
system has a profound effect on cell attachment, and the lentiviral control group is best 
suited to serve as a control for the Myh9 KD group.  The effect of lentivirus exposure 
decreased cell attachment to such an extent that it was difficult to reach a conclusion as to 
the effect of Myh9 KD on cell attachment.  Further work will be needed to accurately 
assess this effect. 
Our studies of focal adhesion (FA) morphology suggest that stretch normally 
increases the number, size, and proportional area of a podocytes taken up by FAs. This 
increase in FA size and number may serve to better anchor the cells to the GBM during 
periods of mechanical strain. When Myh9 is absent this response is markedly altered, 
resulting in a decrease in both size and perhaps more importantly number of FAs per cell. 
The initial larger FAs seen in KD cells may be acting as a compensatory mechanism in 
the absence of NM-IIA, a potential stabilizing agent for these cells against mechanical 
strain. Furthermore, the decrease in FA size after strain in KD cells exclusively could 
suggest that NM-IIA is required for the enlargement of FAs. Consistent with previous 
studies33, knocking down Myh9 resulted in an increase in cell size. It may be inferred that 
the increase in cell size is associated with the increase in FA area, however more data is 
needed to confirm this.  
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 Western blot analysis showed a decrease in NM-IIA in all cells transfected with 
the lentivirus. The observed decrease in NM-IIA in V.CTL cells may indicate some effect 
of the lentiviral exposure on cell synthetic activities, and suggests that this group 
represents the best control for comparison of the effect of NM-IIA knockdown.  The 
greatest decrease in NM-IIA was in the KD-ST cells. Vinculin appeared to show a 
decrease in all stretch groups. This observation supports our hypothesis that stretch alters 
podocytes ability to adhere to the GBM, and is bolstered by our morphometric analysis of 
vinculin.  Our Western blot results should be interpreted with caution, as it was not 
possible to standardize the loaded protein quantity among the lanes due to a technical 
issue with our spectrophotometer.  Nonetheless, based on the strength of the vinculin 
bands it can be inferred that NM-IIA was decreased by some margin, though that margin 
cannot be accurately determined.   
 Taken together, these results suggest Myh9/NM-IIA is necessary for cells to 
bolster cell adhesion structures during events of mechanical stress, and its loss may 
compromise this protective adaptation. In turn, this may increase the cells vulnerability to 
changes in mechanical environment. While these results are mostly in support of our 
hypothesis, almost identical cell detachment was seen in our vector control cells, as 
discussed above (Fig. 9). Furthermore, only a small margin of cells that remained on the 
membrane after stretch were transfected cells. Whether this is due to the efficacy of the 
transduction, the membrane or the handling of the cells is yet to be determined in future 
work. Secondly, the complexity of these experiments (and the number of developmental 
studies needed to prepare for them) limited our ability to perform multiple iterations of 
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the experiment. That being the case, repeat experiments need to be performed to further 
confirm our results. Lastly, this paper only reports the results of cells being stretched for 
24hrs. It is very likely that there are changes occurring very rapidly, such as signaling 
events, that should be looked at, as well as changes after 24hrs.  
One important technical problem with this study concerned the Western blot 
analyses.  It was difficult to make definitive conclusions about changes in relative protein 
concentrations, as lysate concentration measurements were unable to determine protein 
concentration for each experimental group.  This was likely due to low protein 
concentrations for each group, which was at least partly a consequence of the small well 
size in our experimental system.  Future studies in this system where Western blot is 
needed will require experimental “scale up”, with either duplication of experiments and 
additional pooling of lysate samples (while minimizing total lysate volume), or a scale up 
in size of the experimental apparatus. 
 Perhaps the greatest merit of this experiment is in the optimization of all the 
techniques involved in it. While it is clear that much needs to be done to strengthen this 
work, primarily reproduction of the same experiment, this study laid the foundation for 
future projects looking to address the effects of mechanical strain on cells.    
  
Future Studies 
 This study provided novel insight into the role of Myh9 and non-muscle myosin 
IIA as a potential second hit to the effects of hypertension in promoting the progression 
of kidney disease.  However, it does not realistically recapitulate the strain that is likely 
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to be felt by podocytes in vivo. In vivo, mechanical wall stress is likely to be experienced 
in a cyclic fashion in accordance with the cardiac cycle. While this study allowed us to 
examine the effects of step change in strain on podocyte adhesion, future studies with the 
proper tools for stretching cells in a controllable cyclic fashion are necessary.  
 Future studies we would like to do, using techniques optimized in this study, are 
based on the idea that strain not only affects the physiology of podocytes during 
hypertensive states, but alters their ability to recover from this strain. To do this, we 
would cyclically stretch podocytes at a series of time points, similar to this study, then, 
using live cell imaging, monitor the time it takes them to return to a “normal” phenotype.  
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APPENDIX 
 
Flexcell Staining Protocol 
1) Fixation:  
• Remove media from each well and rinse with 1X PBS to remove dead 
cells. Repeat twice 
• Add 1ml 4% PFA to each well and let sit at RT for 5 min 
• Remove fixative and wash with 1X PBS twice 
2) Permeablization: 
• Add 1ml 0.3% TritonX in PBS to each well and let sit at RT for 15 min 
• Rinse 3x with PBS 
3) Move membrane to slide:  
• Cut membrane out along the edge of the well. Cut the membrane into 
equal squares based on the number of staining targets 
• Place membrane on slide in humidified chamber and add 1X PBS to keep 
membrane from drying out. (Amount of PBS required varies according to 
size of membrane, usually between 50-100ul) 
4) Blocking: (All steps to be performed in humidified chamber) 
• Add blocking buffer to membrane (0.3% Triton X, Donkey Serum, Bovine 
Serum Albumin) eg. 3ml BB= 30mg BSA, 150ul DS, 2850ul TritonX 
• Let sit at RT for 45min-1hr 
5) Primary Antibody: 
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• Add primary Ab diluted in BB for 1hr RT 
• Rinse 3x with PBS 
6) Secondary Antibody: 
• Add secondary Ab diluted in PBS to membrane for 45min 
• Rinse 3x with PBS 
7) DAPI or Phalloidin 
• If using phalloidin to label actin, add phalloidin diluted in PBS (1:50 often 
works well) to each membrane and let sit for 45min at RT 
• Rinse 3x with PBS 
• Add DAPI to each membrane and let sit for 3-5min at RT 
8) Mounting: 
• Add a small volume of Dako mounting medium (5-12ul depending on 
membrane size) to each membrane 
• Add a small line of clear nail polish lightly above and below your 
membrane to keep coverslip from sliding 
• Add coverslip to membrane and allow for polish to harden 
• Seal the coverslip on all edges using clear nail polish 
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ImageJ: Creating a Macro for Particle count of Focal Adhesion and Cell Area Tool 
1) Creating a Macro: 
• Open picture file 
• PluginàMacroàRecord (Now every operation you perform will be 
recorded) 
2) Thresholding your image: 
• ImageàTypeà16-bit 
• ImageàAdjustàThreshold  
• Make image B&W 
• Move lower bar (lower limit) all the way to the right (image should have a 
totally white background with black particles) 
• Adjust upper bar (upper limit) so that all the remains are the black FAs 
• Click apply to save your settings 
3) Particle count: 
• AnalyzeàAnalyze Particle 
• Size pixel set at 0-Infinity, Circularity 0.00-1.00, Show nothing 
• Depending on what you need you can choose to show all data, or just 
have data summarized 
4) Running your Macro: 
• ProcessàBatchàMacro 
• Copy and paste your Macro that was recorded into the empty box 
• Select file containing the images you want to analyze 
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• Click “Process”  
All images will then be processed based on the threshold you determined, resulting in the 
area of each FA, the number of FAs. This tool can be used to count cells using their 
DAPI images. 
5) Cell Area: (very similar to above steps) 
• Open image 
• ImageàTypeà16-bit 
• ImageàAdjustàThreshold 
• Select “Over/Under” rather than “B&W” 
• Move bottom bar all the way to the right and adjust top bar so that only the 
cell is visible with as few pixels outside 
• Using the wand tool, click the cell and it will be highlighted along its edge 
• AnalyzeàAnalyze Particlesà Same settings as aboveàProcess 
The image will then be processed based on the pixels within the highlighted boundary, 
giving you the total cell area.   
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